HR 6483 · 117th Congress
Improved Transparency of Foreign Drug Manufacturing Act of 2022
Right now, when pharmaceutical companies make drugs overseas and ship them to the United States, there's a gap in what the government knows about where and how those drugs are actually being made. This bill closes that gap by requiring foreign drug manufacturers to register with the FDA and report detailed informati…
- Sponsor
- Eshoo, Anna G. (D-CA)
- Introduced
- 2022-01-25
- Policy area
- Health
- Latest action
- Referred to the Subcommittee on Health.
Digging through Congress... 🔍